Nonoxynol-9 may increase HIV transmission risk
Kirby, J.
Positive Living 10(5): 20
2001
PMID: 11693101 Document Number: 235050
Document emailed within 1 workday
Related Documents
Gitanjali, B. 1993: Unnecessary injections increase the risk of AIDS transmission World Health Forum 14(3): 291-292Rebe, K.Brian.; De Swardt, G.; Berman, P.A.; Struthers, H.; McIntyre, J.A. 2013: Sexual lubricants in South Africa may potentially disrupt mucosal surfaces and increase HIV transmission risk among men who have sex with men South African Medical Journal 104(1): 49-51
Arambasić, M.B.; Zlatković, V.; Dimitrijević, R.; Ilić, N. 2002: Biological and chemical quality control of spermicidal raw material nonoxynol-9 and nonoxynol-9 containing vaginal contraceptive (ABF contraceptive film): determination of spermicidal activity and assay of nonoxynol-9 Bollettino Chimico Farmaceutico 141(5): 343-347
Arambasić, M.B.; Zlatković, V.; Dimitrijević, R.; Ilić, N. 2002: Biological and chemical quality control of spermicidal raw material nonoxynol-9 and nonoxynol-9 containing vaginal contraceptive (ABF contraceptive film): determination of spermicidal activity and assay of nonoxynol-9 Bollettino Chimico Farmaceutico 141(5): 343-347
Arambasić, M.B.; Zlatković, V.; Dimitrijević, R.; Ilić, N. 2002: Biological and chemical quality control of spermicidal raw material nonoxynol-9 and nonoxynol-9 containing vaginal contraceptive (ABF contraceptive film): determination of spermicidal activity and assay of nonoxynol-9 Bollettino Chimico Farmaceutico 141(5): 343-347
Becquet, R.; Ekouevi, D.K.; Menan, Hé.; Amani-Bosse, C.; Bequet, L.; Viho, I.; Dabis, Fçois.; Timite-Konan, M.; Leroy, Vériane. 2008: Early mixed feeding and breastfeeding beyond 6 months increase the risk of postnatal HIV transmission: ANRS 1201/1202 Ditrame Plus, Abidjan, Côte d'Ivoire Preventive Medicine 47(1): 27-33
Hyun Suk, W.H.A.N.G.; Hunt, M.A.; Wrench, N.; Hockney, J.E.; Farin, C.E.; Tonelli, A.E. 2007: Nonoxynol-9-l-cyclodextrin inclusion compound and its application for the controlled release of nonoxynol-9 spermicide Journal of Applied Polymer Science 106(6): 4104-4109
Mauck, C.K.; Allen, S.; Baker, J.M.; Barr, S.P.; Abercrombie, T.; Archer, D.F. 1997: An evaluation of the amount of nonoxynol-9 remaining in the vagina up to 4 h after insertion of a vaginal contraceptive film (VCF) containing 70 mg nonoxynol-9 Contraception 56(2): 103-110
Trap, R.; Trap, B.; Petersen, S.C. 1990: Evaluation of the amount of nonoxynol in condoms in relation to inhibition of hiv a method based on hplc for detection of nonoxynol Archives of AIDS Research 4(3-4): 301-302
Trap, R.; Trap, B.; Petersen, S.C. 1990: Evaluation of the amount of nonoxynol in condoms in relation to inhibition of hiv a method based on hplc for detection of nonoxynol Archives of AIDS Research 4(3-4): 301-302
Stoové, M.A.; Fry, C.L.; Lintzeris, N. 2008: Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): applications for community-based HCV surveillance, education and prevention Harm Reduction Journal 5: 12
Van Damme, L.; Niruthisard, S.; Atisook, R.; Boer, K.; Dally, L.; Laga, M.; Lange, J.M.; Karam, M.; Perriens, J.H. 1998: Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection Aids 12(4): 433-437
Simonds, R.J.; Steketee, R.; Nesheim, S.; Matheson, P.; Palumbo, P.; Alger, L.; Abrams, E.J.; Orloff, S.; Lindsay, M.; Bardeguez, A.D.; Vink, P.; Byers, R.; Rogers, M. 1998: Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. Perinatal AIDS Collaborative Transmission Studies Aids 12(3): 301-308
Ndong-Atome, G.-R.; Njouom, R.; Padilla, C.; Bisvigou, U.; Makuwa, M.; Kazanji, M. 2009: Absence of intrafamilial transmission of hepatitis C virus and low risk for sexual transmission in rural central Africa indicate a cohort effect Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 45(4): 349-353
Joshi, S.; Joglekar, N.; Ghate, M.; Unni, J.; Risbud, A.; Bentley, M.; Shepherd, M.; Bollinger, R.; Mehendale, S. 2003: Phase i safety and preliminary acceptability of nonoxynol-9 vaginal pessary as a vaginal microbicide in low risk women in Pune, India Indian Journal of Medical Research 117: 152-157
Persson, I. 1996: New discoveries on oral contraceptives and risk of breast cancer. International data show a moderate increase in risk Lakartidningen 93(50): 4613-4616
Persson, I. 1996: New discoveries on oral contraceptives and risk of breast cancer. International data show a moderate increase in risk Lakartidningen 93(50): 4613-4616
Hancart Petitet, P. 2010: Les pratiques de soins de santé de la reproduction sont-elles à risques de transmission du VIH, du VHB et du VHC ? Études de cas au Cambodge - Do reproductive health care practices create a risk of HIV, HVB, and HVC transmission? Case studies in Cambodia Sante (Montrouge) 20(1): 3-8
Perez, G.; Skurnick, J.H.; Denny, T.N.; Stephens, R.; Kennedy, C.A.; Regivick, N.; Nahmias, A.; Lee, F.K.; Lo, S.C.; Wang, R.Y.; Weiss, S.H.; Louria, D.B. 1998: Herpes simplex type II and Mycoplasma genitalium as risk factors for heterosexual HIV transmission: report from the heterosexual HIV transmission study International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 3(1): 5-11
Le Lannou, D.; Colleu, D.; Blanchard, D. 1988: Effets in vitro d'un spermicide vaginal, le nonoxynol 9 ou Patentex ovule - In vitro effects of vaginal spermicid: nonoxynol 9 or Patentex Contraception Fertilite Sexualite (1973) 16(1): 20-22